TORNADO THERAPEUTICS Trademark

Trademark Overview

On Monday, March 28, 2022, a trademark application was filed for TORNADO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TORNADO THERAPEUTICS trademark a serial number of 97334141. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, May 8, 2024. This trademark is owned by Cambrian BioPharma, Inc.. The TORNADO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway
tornado therapeutics

General Information

Serial Number97334141
Word MarkTORNADO THERAPEUTICS
Filing DateMonday, March 28, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, May 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the prevention of age-related physical decline, age-related diseases, infectious diseases, and Covid-19; pharmaceutical preparations and substances for the treatment of autoimmune diseases and inflammatory conditions, infectious diseases, fungal infections, mitochondrial myopathy and mitochondrial stress, oncology indications, metabolic indications, cardiovascular indications, neurodegenerative indications, and indications mediated by the mTOR pathway
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 1, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCambrian BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10003
Party NameCambrian BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10003

Trademark Events

Event DateEvent Description
Thursday, March 31, 2022NEW APPLICATION ENTERED
Friday, April 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Monday, January 9, 2023NON-FINAL ACTION WRITTEN
Monday, January 9, 2023NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 9, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 9, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 9, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, March 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 1 FILED
Tuesday, December 12, 2023SOU EXTENSION 1 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 8, 2024DIVISIONAL REQUEST RECEIVED
Monday, April 8, 2024SOU EXTENSION 2 FILED
Monday, April 8, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, April 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 8, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, May 8, 2024SOU EXTENSION 2 GRANTED
Thursday, May 9, 2024CORRECTED NOA E-MAILED
Thursday, May 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics tornado indications diseases mitochondrial pharmaceutical infectious substances related preparations oncology stress